You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • RELATIONSHIP OF TIME TO RELAPSE (TTR) AND SURVIVAL POST RELAPSE (SPR): EXPLORATION OF RISK FACTORS FROM THE FOLLOW-UP DATASET OF A RANDOMIZED PBO-CONTROLLED STUDY OF OREGOVOMAB (OV) AS A CONSOLIDATION THERAPY FOR PATIENTS WITH ADVANCED OVARIAN CANCER (OC)

Citation Tools

Article menu
Abstract
Free Communications
RELATIONSHIP OF TIME TO RELAPSE (TTR) AND SURVIVAL POST RELAPSE (SPR): EXPLORATION OF RISK FACTORS FROM THE FOLLOW-UP DATASET OF A RANDOMIZED PBO-CONTROLLED STUDY OF OREGOVOMAB (OV) AS A CONSOLIDATION THERAPY FOR PATIENTS WITH ADVANCED OVARIAN CANCER (OC)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Berek J, Taylor P, Schultes B, et al
RELATIONSHIP OF TIME TO RELAPSE (TTR) AND SURVIVAL POST RELAPSE (SPR): EXPLORATION OF RISK FACTORS FROM THE FOLLOW-UP DATASET OF A RANDOMIZED PBO-CONTROLLED STUDY OF OREGOVOMAB (OV) AS A CONSOLIDATION THERAPY FOR PATIENTS WITH ADVANCED OVARIAN CANCER (OC)
International Journal of Gynecologic Cancer 2004;14:16.